Bavarian Nordic A/S will acquire two oral vaccines from Emergent BioSolutions for a total consideration of up to $380 million, to strengthen its position in the travel vaccines space. The acquisition is expected to help Bavarian Nordic expand its US commercial sales, marketing, and distribution network, as well as increased scale in additional European markets. […]
Emergent BioSolutions said that it has dosed the first participant in a phase 3 clinical trial of CHIKV VLP — the company’s single-dose chikungunya vaccine candidate. The American biopharma company will test the safety and immunogenicity of the investigational chikungunya virus (CHIKV) virus-like particle (VLP) vaccine. According to Emergent BioSolutions, CHIKV VLP is the only […]
Chikungunya is a viral fever transmitted by mosquitoes and spreads in humans by the bite of Aedes mosquitoes infected with Chikungunya virus. In this post let us see the answers for few questions like: Which mosquitoes carry chikungunya? How long does chikungunya last in our body? How much time does it take to recover from […]